Open AccessObstetrical and neonatal outcome after controlled ovarian stimulation for IVF using the GnRH antagonist ganirelix
Author(s) -
Peter J. Boerrigter
Publication year - 2002
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/17.8.2027
Subject(s) - medicine , antagonist , stimulation , hormone antagonist , gonadotropin releasing hormone antagonist , gynecology , obstetrics , gonadotropin releasing hormone , endocrinology , luteinizing hormone , hormone , receptor
To establish long-term safety, follow-up data on pregnancy, birth and neonatal outcome were collected during clinical development trials with ganirelix (Orgalutran) in women undergoing controlled ovarian stimulation for conventional IVF or ICSI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom